• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Amano Takahiro  天野 孝広

ORCIDConnect your ORCID iD *help
Researcher Number 80836908
Other IDs
Affiliation (based on the past Project Information) *help 2022 – 2023: 大阪大学, 医学部附属病院, 医員
Review Section/Research Field
Principal Investigator
Basic Section 53010:Gastroenterology-related
Keywords
Principal Investigator
Cytometric Bead Array / 糖タンパク質 / バイオマーカー / 治療選択 / 炎症性腸疾患
  • Research Projects

    (1 results)
  • Research Products

    (8 results)
  •  Optimization of molecular targeted treatment effectiveness in patients with inflammatory bowel disease based on novel glycoprotein markersPrincipal Investigator

    • Principal Investigator
      Amano Takahiro
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53010:Gastroenterology-related
    • Research Institution
      Osaka University

All 2024 2023 2022

All Presentation

  • [Presentation] Pretreatment Levels of Serum Leucine-rich Alpha-2 Glycoprotein is Useful for Selection of Anti-Cytokine Biologics in Patients with Inflammatory Bowel Disease: A Multicenter Prospective Cohort Study by the Osaka Gut Forum2024

    • Author(s)
      Satoshi Hiyama, Takahiro Amano, Takeo Yoshihara, Shinichiro Shinzaki, et al.
    • Organizer
      Digestive Disease Week 2024
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K15965
  • [Presentation] クローン病患者に対する生物学的製剤の治療効果予測マーカーとしての血清LRGの可能性2024

    • Author(s)
      天野孝広、良原丈夫、榊原祐子、山田拓哉、大杉直人、村山洋子、日山智史、新﨑信一郎、林義人、竹原徹郎
    • Organizer
      第110回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-22K15965
  • [Presentation] Serum Leucine-rich Alpha-2 Glycoprotein Can be a Biomarker for Selecting Anti-cytokine Biologics in Patients with Inflammatory Bowel Disease: A Multicentre Prospective Cohort Study2024

    • Author(s)
      Takahiro Amano, Takeo Yoshihara, Shinichiro Shinzaki, et al.
    • Organizer
      19th Congress of European Crohn's and Colitis Organisation
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K15965
  • [Presentation] 潰瘍性大腸炎における非抗TNF生物学的製剤の短期治療効果:多施設共同前向き観察研究2023

    • Author(s)
      天野孝広、良原丈夫、辻井悠里、朝倉亜希子、田代拓、大竹由利子、谷瑞季、井上隆弘、林義人、竹原徹郎
    • Organizer
      第14回日本炎症性腸疾患学会
    • Data Source
      KAKENHI-PROJECT-22K15965
  • [Presentation] 高齢潰瘍性大腸炎患者における非抗TNF生物学的製剤の有効性と安全性2023

    • Author(s)
      天野孝広
    • Organizer
      日本消化器病学会近畿支部第118回例会
    • Data Source
      KAKENHI-PROJECT-22K15965
  • [Presentation] 高齢潰瘍性大腸炎患者における生物学的製剤の有効性と安全性2023

    • Author(s)
      天野孝広
    • Organizer
      第109回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-22K15965
  • [Presentation] IBD患者に対するUstekinumab治療の寛解導入期における血清LRG測定の有用性2023

    • Author(s)
      天野孝広、良原丈夫、林義人、竹原徹郎
    • Organizer
      日本消化器病学会近畿支部第119回例会
    • Data Source
      KAKENHI-PROJECT-22K15965
  • [Presentation] Adalimumab・Ustekinumabによる長期寛解維持のための寛解導入期LRG測定の有用性2022

    • Author(s)
      天野孝広
    • Organizer
      第13回日本炎症性腸疾患学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K15965

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi